A Germany-based pharmaceutical multinational is set to trial IBM blockchain in Canada in a bid to raise the quality of clinical trials.
Tuesday that it has partnered with IBM "To improve trust, transparency, patient safety and patient empowerment in clinical trials" using the tech giant's blockchain platform.
The firm said the trial aims to address quality issues with clinical trial processes and records, which are currently "Often erroneous or incomplete" and could potentially put patient safety at risk.
The project will test how blockchain can help provide a decentralized framework that preserves the integrity of data, provides "Provenance and transparency," and enables the automation of processes, ultimately boosting patient safety and reducing costs.
"The clinical trial ecosystem is highly complex as it involves different stakeholders, resulting in limited trust, transparency and process inefficiencies without true patient empowerment," said Dr. Uli Brödl, vice president for medical and regulatory affairs at Boehringer Ingelheim.
"We've been using blockchain in other industries, and we are now investigating how we can use this technology to give Canadian patients the same level of security and trust when it comes to their personal health information."
Other major pharmaceutical firms have also been exploring the potential benefits of integrating blockchain tech.
In January 2018, Pfizer, Amgen and Sanofi were eyeing blockchain as a way of streamlining the process of developing and testing new drugs.
Last June, Merck was seeking a patent for a way to use blockchain in order to track goods as they move through the supply chain and tackle the issue of counterfeit meds.
Indian government think tank NITI Aayog was also working on a blockchain solution aimed to combat the country's roaring counterfeit drugs trade last April.
Pharma Giant Trials IBM Blockchain in Bid to Improve Clinical Trials
gepubliceerd op Feb 13, 2019
by Coindesk | gepubliceerd op Coinage
Coinage
Recent nieuws
Alles zien
Blockchain Bites: Bitcoin's Run, Uniswap's Hemorrhaging Value, Anchorage's Banking Bid
Bitcoin is nearing all-time highs in price and market cap last set three years ago.
Japan's megabanks to lead experiment with digital yen
We have, in order, Cheese Bank with a $3.3 million theft, Akropolis with its $2 million loss, Value DeFi with a whopping $6 million exploit and finally Origin Protocol's loss of $7 million.
Number of new Bitcoin addresses spikes amid growing FOMO
Japan's three largest banks, as part of a group of 30 private sector actors, are set to collaborate on an experiment with a digital yen.
Not just Wall Street: Quant trader explains why Bitcoin price is going up
Sam Trabucco, a quantitative trader at Alameda Research, believes four general factors are pushing up the price of Bitcoin.